Profile avatar
ebtapper.bsky.social
Hepatologist. #LiverSky / LiverLand. #MedSky. #cirrhosis Academic Chief of Hepatology at University of Michigan. Editor, Hepatology Communications. Kid Chauffeur
475 posts 2,431 followers 438 following
Prolific Poster

DDAVP for bleeding with incisions. Meh pubmed.ncbi.nlm.nih.gov/3513867/

Big meetings should provide real-time translation for at least the conferences centerpieces - named lectures, presidential plenaries.

🚨Check out our new study in @jhepatology.bsky.social ❗️ Using natural language processing to identify >350,000 patients with #steatosis, we demonstrated that cause-specific mortality differs between #MASLD #MetALD and #ALD www.journal-of-hepatology.eu/article/S016...

🚨 Hot off the press! Our study is the first to define meaningful score differences (MSDs) for PROMIS, CLDQ & SF-36 in CLD - key to making PROMs clinically actionable! 🔗 journals.lww.com/hepcomm/Full... #LiverSky #GastroSky @aasldnews.bsky.social

There are two articles in NEJM this year that say naltrexone is 'contraindicated for cirrhosis'. This saddens me. It is not supported by an evidence. Alcohol is 'contraindicated for cirrhosis'. That is supported by evidence

An important message on naltrexone in patients with liver disease: ✅Naltrexone can help reduce alcohol use without harming the liver. 🚫Alcohol DOES harm the liver. We do not need any more barriers to treat patients with AUD➕ALD! @nejm.org @ebtapper.bsky.social www.nejm.org/doi/full/10....

Science and fun @hospitalclinic.bsky.social @idibaps.bsky.social @ebtapper.bsky.social @rbataller.bsky.social

It was an absolute delight to contribute to this high-impact work with @tom-marjot.bsky.social and @mattarmstrong95.bsky.social in which we review all things #MASLD and #Muscle! If you're looking for holiday weekend reading, look no further: journals.lww.com/hepcomm/page... @ebtapper.bsky.social

See you at the liver meeting

There you have it: BEDMED published in @jama.com jamanetwork.com/journals/jam... h/t @drjmluther.bsky.social No difference in bedtime versus morning BP meds - as expected #NephSky #Hypertension 1/

A patient with cirrhosis doubled their bowling score after starting lactulose #CovertHE

We have work to do!!! journals.lww.com/hepcomm/full...

Feel free to follow the new A-TANGO Consortium + #hepatology Starter Pack go.bsky.app/Tc8YSWq #LiverSky #LiverResearch #LiverDisease #hepatitis #cirrhosis #ACLF #HepatologyJournals @rajivjalan.bsky.social @europeliver.bsky.social @easlnews.bsky.social @jhepatology.bsky.social @ebtapper.bsky.social

Important things to teach our patients (and each other!) #foodismedicine #worldliverday

Celebrating #worldliverday with high protein bagel breakfast sandwich @heathernp.bsky.social @ebtapper.bsky.social @orenfix.bsky.social @aasldnews.bsky.social

Fantastic to see the updated BSG/BASL decompensated cirrhosis admission bundle in print at FG - practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter fg.bmj.com/content/earl...

This trend is *very* concerning given that alcohol damages the liver of females at 2x the rate of males. We are seeing so many young females (20s and 30s) who get very sick and often die from🍸🍷🍻-associated liver disease! We need to work on strategies to 📉 alcohol use in this population! #liversky

A pharmacist told a patient they don’t make acamprosate any more and I need to find an alternative Another pharmacy says it is on back order What is the deal? Anyone else seeing this?

A study by Perez-campuzano and @juanc60.bsky.social that randomizes patients with portal hypertension to two terlipressin strategies and octreotide and shows no significant change in portal pressure #liversky

Management of ascites by a bunch of radiologists and my friend @brettefortune.bsky.social doi.org/10.2214/ajr.... #liversky

"Food is Medicine" -But for whom? The accessibility problem in nutrition and liver health: worldliverday.org/food-is-medi... #WorldLiverDay #SLDthinktank #LiverSky @easlnews.bsky.social @ebtapper.bsky.social @aleksanderkrag.bsky.social @debbieshawcross.bsky.social @melinamanolas.bsky.social

❤️

Everything you need to know about terlipressin journals.lww.com/hepcomm/full...

Let’s talk about sex journals.lww.com/hepcomm/full... #liversky

An early look at how resmetirom is being used and impacts patients with MASH journals.lww.com/hepcomm/full... #liversky

With rising burden of metabolic diseases we are struggling with management of ascites in CKD. Here we try to answer them & provide an overview of approach to ascites in ESRD. @ebtapper.bsky.social @akashroyy.bsky.social journals.lww.com/hepcomm/full...

Here is an update on the cirrhosis epidemiology in Denmark: doi.org/10.1016/j.jh... * Median age at cirrhosis diagnosis up from 56y in 1998 to 66y in 2022 * Proportion with ALD cirrhosis down from 80% to 58% * Prevalence of cirrhosis peaked in 2024 * Survival has improved #Liversky

I frequently see patients with “new” cirrhosis only to find that on chart review they had low platelets/some other finding concerning for cirrhosis or liver disease often YEARS before. Thrombocytopenia should prompt a search for cirrhosis and may save lives/livers! #liversky

Congrats to Thailand for nearly eliminating vertical transmission of hepatitis B The vaccine works doi.org/10.12932/ap-...

In this study 25 patients switched from a non-nucleoside reverse tran-scriptase inhibitor-based regimen to bictegravir/emtricitabine/TAF And their liver fat was substantially decreased on serial fibroscan www.mdpi.com/1999-4915/17... #liversky #idsky

FRESH-UP Trial #ACC25 #medsky RCT comparing liberal vs restricted fluid intake (≤1500 ml/d) in 504 pts with stable chronic HF 🌊No difference in status health quantified by Kansas City Cardiomyopathy Questionnaire at 3 mths 🌊 More thirst distress with restriction www.nature.com/articles/s41...

As official communication has not occurred the University of Michigan could still make a different choice. Choose to be on the right side of history. @umichlaw.bsky.social @umichfball.bsky.social @umichlawlib.bsky.social @umichstonecid.bsky.social @iwashyna.bsky.social @ebtapper.bsky.social

“Moderate” alcohol-associated hepatitis MELD < 20 journals.lww.com/hepcomm/full... #liversky

The liver loves aerobic exercise journals.lww.com/hepcomm/full... #liversky

Love this study #liversky journals.lww.com/hepcomm/full... @juanpabloarab.bsky.social

#AmericanSocietyOfHematology roadmap to designing representative #clinicaltrials Recommendations include results from stakeholder surveys and focus groups Led by #AKubian #RareDiseases #RCTdesign ashpublications.org/bloodadvance...

The way that screening for liver disease will work best is by doing it in at-risk groups journals.lww.com/hepcomm/full... Huge Hep Comm paper by @fredrikaberg.bsky.social #liversky

Australia has so many beautiful animals This guy just walked up to me

When the bilirubin is high (or goes higher), I worry first about infection In this study, the ATTIRE team shows that bilirubin predicts infection in hospitalized patients journals.lww.com/hepcomm/full...

Not good!

Went to Sydney, saw one of the most innovative GI units in the world (led by Amany Zekry), met the trainees at the St George (future of Australian GI) and got tips on being a journal editor from a world class human (Emad El-Omar)